1. Home
  2. NBY vs HPI Comparison

NBY vs HPI Comparison

Compare NBY & HPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.48

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Logo John Hancock Preferred Income Fund of Beneficial Interest

HPI

John Hancock Preferred Income Fund of Beneficial Interest

HOLD

Current Price

$16.02

Market Cap

433.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBY
HPI
Founded
2000
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
31.6M
433.9M
IPO Year
2007
2002

Fundamental Metrics

Financial Performance
Metric
NBY
HPI
Price
$1.48
$16.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
954.5K
62.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
35.42
N/A
EPS
0.76
N/A
Revenue
$370,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$32.05
N/A
P/E Ratio
$1.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$14.61
52 Week High
$19.95
$17.61

Technical Indicators

Market Signals
Indicator
NBY
HPI
Relative Strength Index (RSI) 46.21 42.35
Support Level $0.99 $15.71
Resistance Level $2.52 $16.28
Average True Range (ATR) 0.22 0.14
MACD 0.16 -0.02
Stochastic Oscillator 50.68 21.28

Price Performance

Historical Comparison
NBY
HPI

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About HPI John Hancock Preferred Income Fund of Beneficial Interest

John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high-level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.

Share on Social Networks: